Health News Releases

  • Today October 19
August 04, 09:50
First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC
SS&C Technologies Holdings, Inc. (https://www.ssctech.com/?utm_campaign=SSC2026-Enterprise-Press-Release-0826&utm_medium=pressrelease&utm_source=prnews&utm_content=First-Plus-SSNC) (Nasdaq: SSNC) toda
July 31, 13:40
White Paper Examines Early Clinical Development of B-Cell Depletion Therapies in Autoimmune Disease
Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, B-Cell Depletion in Autoimmune Disease: Considerations for
July 30, 15:52
Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track
Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54578194&newsitemid=20260727883646&lan=en-US&anc
July 30, 15:40
VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System
VDyne Inc. (“VDyne”), a privately held medical device company developing an innovative transcatheter tricuspid valve replacement (TTVR) system, today announced that the first patient has been enrolled
July 30, 15:30
Copeland Enters into Exclusive Negotiations to Acquire Dickson, Advancing Cold Chain Leadership
Copeland, a global leader in compression technologies and controls solutions, today announced its entry into exclusive negotiations towards the purchase of Dickson, a portfolio company of May River Ca
July 30, 11:50
Xpress Genomics Joins Parse Biosciences’ Certified Service Provider Network
Parse Biosciences (https://www.parsebiosciences.com/), the leading provider of scalable and accessible single cell sequencing, and a QIAGEN company, today announced that Xpress Genomics (https://xpres
July 24, 16:41
Samsung Epis Holdings Reports Second Quarter and Half-Year 2026 Financial Results
Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced its financial results for the second quarter and first half
July 24, 11:15
Kirin and Blackmores Team Up to Release Cognitive Function Support Supplements in Australia and New Zealand Formulated with Kirin Group’s Cognizin® Citicoline
Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and Blackmores Limited (Blackmores), Kirin’s group company and Australia’s leading natural health company, are proud to announce the launch
July 23, 15:31
Galderma Reports Record First Half 2026 Net Sales of 3.134 Billion USD and 24.6% Year-on-Year Growth at Constant Currency, Raises Net Sales Guidance for the Full Year
Galderma Group AG (SIX: GALD), the pure-play dermatology category leader, today announced its financial results for the first half of 2026. · Net sales reached 3.134 billion USD, surpassing 3 billi
July 22, 11:30
Zayed Sustainability Prize’s Beyond2020 Initiative Strengthens Healthcare Resilience for Over 200,000 People in India
Beyond2020, the flagship initiative launched by the Zayed Sustainability Prize, the UAE’s pioneering award for innovative solutions to global challenges, today announced the deployment of solar-powere
July 21, 14:20
Brenus Pharma Welcomes New European and Asia-Pacific Life Sciences Investors in Series A Extension
Brenus Pharma today announced an €11 million ($12.6M) extension to its Series A round, bringing total capital raised since inception to €38 million ($43.5M). This funding reflects strong execution acr
July 21, 13:30
HistoSonics Opens Expanded Histotripsy Training Center in Hong Kong
HistoSonics today announced the opening of its expanded Histotripsy Training Center in Hong Kong, reinforcing the city’s position as a leading hub for physician education, clinical collaboration, and
July 21, 09:25
Clinigen Appoints Greg Skalicky as Chief Executive Officer
Clinigen, the global pharmaceutical services company dedicated to accelerating access to critical medicines worldwide, today announced the appointment of Greg Skalicky as Group Chief Executive Officer
July 20, 15:30
Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of Alastin - its premium regenerative skincare brand - across the JPAC region. The brand recently launched i
July 19, 13:51
Aqemia and Sanofi Expand Their Research Collaboration
Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the
July 19, 13:30
Crown Bioscience Joins C-Path's NAMs Developer Coalition to Advance Human-Relevant Models in Drug Development
Crown Bioscience (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.crownbio.com%2F&esheet=54570432&newsitemid=20260716657544&lan=en-US&anchor=Crown+Bioscience&index=1&md5=de38f797
July 19, 13:05
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54571620&newsitemid=20260716820927&lan=en-US&anchor=TSE%3A4
July 19, 11:50
Garvan Institute of Medical Research Joins Parse Biosciences’ Certified Service Provider Network
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fparsebiosciences.com&esheet=54570389&newsitemid=20260715791600&lan=en-US&anchor=Parse+Biosciences&index=1&md5=9f32bd
July 19, 11:30
Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active Liver Metastases at ESMO GI 2026
Agenus (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.agenusbio.com&esheet=54564391&newsitemid=20260706344475&lan=en-US&anchor=Agenus&index=1&md5=19d18ed2bf133f951b7929138bb9ddf
HistoSonics Edison® Histotripsy System
July 16, 13:30
HistoSonics Receives CE Mark, Unlocking Access Across Europe and Accelerating Global Commercialization of the Edison® Histotripsy Platform
HistoSonics (https://histosonics.com/), today announced that the company has received CE Mark approval in Europe for its Edison® System, enabling commercialization of the company’s non-invasive histot
July 16, 12:00
Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer
Agenus (https://www.agenusbio.com/) Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that it has entered into a securities purchase agreement for a private placement of app
July 15, 16:10
Neuraptive Therapeutics Licenses Innovative Bioresorbable Nerve Stimulation Technology from Washington University in St. Louis
Neuraptive Therapeutics, Inc., a clinical-stage biotech company focused on peripheral nerve injuries, announced today that it has secured an exclusive license from Washington University in St. Louis f
July 15, 16:00
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nomin
July 15, 09:40
European Commission Approves Erbitux® (cetuximab) in Combination with Encorafenib and FOLFOX for First-Line Treatment of Metastatic Colorectal Cancer with BRAF V600E Mutation
Merck, a leading global science and technology company, today announced that the European Commission (EC) approved an update to the Erbitux (cetuximab) EU label on June 26, 2026. Erbitux is now indica
Actus Nutrition achieves Certified B Corporation status.
July 14, 13:40
Actus Nutrition Achieves Certified B Corporation™ Status
Actus Nutrition today announced that it has achieved Certified B Corporation™ status, joining a global community of businesses that value social and environmental performance, accountability, and tran
25 per page50 per page75 per page100 per page